banner
CREKA peptide-modified docetaxel-loaded liposomes (CREKA-lipo-DTX)
Inquiry

Cat. No.: X26-05-ZQ1658

CREKA peptide-modified docetaxel-loaded liposomes (CREKA-lipo-DTX)

Synonym: CREKA peptide docetaxel liposomes; CREKA-modified DTX-loaded LPs; CREKA-lipo-DTX

img
Product Size
100 mg; 250 mg; 500 mg; 1 g; 5 g
Price
Datasheet
MSDS
Properties
Description
This formulation features CREKA pentapeptide-modified docetaxel-loaded liposomes (CREKA-lipo-DTX) engineered with a sterically stabilized affinity surface. The vesicular structure incorporates the hydrophobic taxane docetaxel (DTX) directly into the hydrocarbon tail region of a stable phospholipid bilayer, while the exterior surface is functionalized with specific cysteine-arginine-glutamic acid-lysine-alanine (CREKA) tumor stroma-targeting pentapeptides linked via polymer-lipid anchors. This surface modification alters the overall surface topography, membrane packing density, and surface charge profile. The resulting vesicles exhibit high colloidal stability and provide a defined model for peptide surface interaction assays in cell-free environments.
Source
Custom synthesis
Functional Group
CREKA peptide; Docetaxel
Form
Solid or powder
Purity
≥95%
Impurities
No visible impurities to the naked eye.
Identity
HPLC/MS/NMR
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products

About Us

CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.

Contact Us

  • For research and manufacturing partners only. Not intended for (direct) human or veterinary use.
Copyright © CD BioGlyco. All rights reserved.